Expression of somatostatin receptor subtype 2 in growth hormone-secreting pituitary adenoma and the regulation of miR-185

Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study¹

Stephen M. Orme, Richard McNally, Ray A. Cartwright et al. · The Journal of Clinical Endocrinology & Metabolism · 1998 · 809 citations · Full text

Medicine, Health Sciences, Oncology +15

Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly¹

Brooke Swearingen, Fred G. Barker, Laurence Katznelson et al. · The Journal of Clinical Endocrinology & Metabolism · 1998 · 587 citations · Full text

Medicine, Endocrinology, Surgery +14

Quantitative analysis of somatostatin receptor subtype (SSTR1–5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas

Giselle Fernandes Taboada, Raúl M. Luque, Wildebranham Bastos et al. · European Journal of Endocrinology · 2007 · 222 citations

Medicine, Endocrinology, Oncology +17

Determinants of Survival in Treated Acromegaly in a Single Center: Predictive Value of Serial Insulin-Like Growth Factor I Measurements

Nienke R. Biermasz, Friedo W. Dekker, Alberto M. Pereira et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 195 citations · Full text

Medicine, Endocrinology, Surgery +15

MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers

J. Saadi Imam, Kalyan Buddavarapu, Jennifer S. Lee-Chang et al. · Oncogene · 2010 · 175 citations

Medicine, Molecular Biology, Oncology +14